258 related articles for article (PubMed ID: 28679291)
1. Promising investigational drug candidates in phase I and phase II clinical trials for mesothelioma.
Guazzelli A; Bakker E; Tian K; Demonacos C; Krstic-Demonacos M; Mutti L
Expert Opin Investig Drugs; 2017 Aug; 26(8):933-944. PubMed ID: 28679291
[TBL] [Abstract][Full Text] [Related]
2. What can independent research for mesothelioma achieve to treat this orphan disease?
Guazzelli A; Meysami P; Bakker E; Bonanni E; Demonacos C; Krstic-Demonacos M; Mutti L
Expert Opin Investig Drugs; 2019 Aug; 28(8):719-732. PubMed ID: 31262194
[No Abstract] [Full Text] [Related]
3. Emerging drugs for mesothelioma.
Scagliotti GV; Selvaggi G
Expert Opin Emerg Drugs; 2007 Mar; 12(1):127-37. PubMed ID: 17355218
[TBL] [Abstract][Full Text] [Related]
4. Therapies currently in Phase II trials for malignant pleural mesothelioma.
Pinton G; Manente AG; Tavian D; Moro L; Mutti L
Expert Opin Investig Drugs; 2013 Oct; 22(10):1255-63. PubMed ID: 23815672
[TBL] [Abstract][Full Text] [Related]
5. Review on clinical trials of targeted treatments in malignant mesothelioma.
Jakobsen JN; Sørensen JB
Cancer Chemother Pharmacol; 2011 Jul; 68(1):1-15. PubMed ID: 21553148
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy for malignant pleural mesothelioma.
Janne PA
Clin Lung Cancer; 2003 Sep; 5(2):98-106. PubMed ID: 14596692
[TBL] [Abstract][Full Text] [Related]
7. Malignant pleural mesothelioma: current treatments and emerging drugs.
Belli C; Fennell D; Giovannini M; Gaudino G; Mutti L
Expert Opin Emerg Drugs; 2009 Sep; 14(3):423-37. PubMed ID: 19552609
[TBL] [Abstract][Full Text] [Related]
8. Targeted therapies in malignant pleural mesothelioma: a review of clinical studies.
Greillier L; Marco S; Barlesi F
Anticancer Drugs; 2011 Mar; 22(3):199-205. PubMed ID: 21263312
[TBL] [Abstract][Full Text] [Related]
9. Advances in the systemic therapy of malignant pleural mesothelioma.
Fennell DA; Gaudino G; O'Byrne KJ; Mutti L; van Meerbeeck J
Nat Clin Pract Oncol; 2008 Mar; 5(3):136-47. PubMed ID: 18227828
[TBL] [Abstract][Full Text] [Related]
10. Anti-angiogenic therapies for malignant pleural mesothelioma.
Ceresoli GL; Zucali PA
Expert Opin Investig Drugs; 2012 Jun; 21(6):833-44. PubMed ID: 22519641
[TBL] [Abstract][Full Text] [Related]
11. Investigational therapies currently in Phase II clinical trials for the treatment of pelvic serous carcinomas.
Bergamini A; Leone Roberti Maggiore U; Ferrero S; Rabaiotti E; Viganò R; Petrone M; De Marzi P; Salvatore S; Candiani M; Mangili G
Expert Opin Investig Drugs; 2015 Mar; 24(3):345-62. PubMed ID: 25640877
[TBL] [Abstract][Full Text] [Related]
12. Systemic drug therapy of malignant pleural mesothelioma.
Ardizzoni A; Grossi F; Pennucci MC
Monaldi Arch Chest Dis; 1998 Apr; 53(2):236-40. PubMed ID: 9689814
[TBL] [Abstract][Full Text] [Related]
13. Investigational drugs for the treatment of cervical cancer.
Barra F; Lorusso D; Leone Roberti Maggiore U; Ditto A; Bogani G; Raspagliesi F; Ferrero S
Expert Opin Investig Drugs; 2017 Apr; 26(4):389-402. PubMed ID: 28274154
[TBL] [Abstract][Full Text] [Related]
14. Phase II trials in mesothelioma: an increasing challenge.
Nowak AK
Lung Cancer; 2005 Oct; 50(1):87-90. PubMed ID: 16026892
[No Abstract] [Full Text] [Related]
15. Immunotherapy advances for mesothelioma treatment.
Bakker E; Guazzelli A; Ashtiani F; Demonacos C; Krstic-Demonacos M; Mutti L
Expert Rev Anticancer Ther; 2017 Sep; 17(9):799-814. PubMed ID: 28724330
[TBL] [Abstract][Full Text] [Related]
16. Pemetrexed in malignant pleural mesothelioma.
Hazarika M; White RM; Booth BP; Wang YC; Ham DY; Liang CY; Rahman A; Gobburu JV; Li N; Sridhara R; Morse DE; Lostritto R; Garvey P; Johnson JR; Pazdur R
Clin Cancer Res; 2005 Feb; 11(3):982-92. PubMed ID: 15709163
[TBL] [Abstract][Full Text] [Related]
17. Combination of raltitrexed and oxaliplatin is an active regimen in malignant mesothelioma: results of a phase II study.
Fizazi K; Doubre H; Le Chevalier T; Riviere A; Viala J; Daniel C; Robert L; Barthélemy P; Fandi A; Ruffié P
J Clin Oncol; 2003 Jan; 21(2):349-54. PubMed ID: 12525529
[TBL] [Abstract][Full Text] [Related]
18. A Potential Immune Therapy for Mesothelioma.
Cancer Discov; 2015 Jul; 5(7):OF14. PubMed ID: 25956959
[No Abstract] [Full Text] [Related]
19. Pleural mesothelioma: a snapshot of emerging drug targets and opportunities for non-surgical therapeutic advancement.
Assié JB; Jean D
Expert Opin Ther Targets; 2023; 27(11):1059-1069. PubMed ID: 37902459
[TBL] [Abstract][Full Text] [Related]
20. Investigational therapies for squamous cell lung cancer: from animal studies to phase II trials.
Shum E; Wang F; Kim S; Perez-Soler R; Cheng H
Expert Opin Investig Drugs; 2017 Apr; 26(4):415-426. PubMed ID: 28277882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
